Altered molecular mechanisms of diabetic foot ulcers

International Journal of Lower Extremity Wounds

Volumn 8, Issue 2, 2009, Pages 95-104

  Blakytny, Robert ^a   Jude, Edward B ^b  

^a UNIVERSITY OF ULM   (Germany)

^b TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Chronic wound; Diabetes; Extracellular matrix; Growth factors; Nerve regeneration

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ARTICLE; ARTIFICIAL SKIN; DIABETIC FOOT; EPITHELIZATION; EXTRACELLULAR MATRIX; HUMAN; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN GRAFT; WOUND HEALING;

DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FOOT ULCER; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NERVE REGENERATION;

EID: 65649129727     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734609337151     Document Type: Article

References (90)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 ; 27: 1047-1053. (Pubitemid 38579764)
2. Li Z., Bowerman S., Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am. 2005 ; 85: 681-701. (Pubitemid 41095465)
3. Hall CA, Jacques PF Weighing in on the issues of type 2 diabetes in children: a review. Pediatr Phys Ther. 2007 ; 19: 211-216. (Pubitemid 47262954)
4. Gale EA The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002 ; 51: 3353-3361. (Pubitemid 35403436)
5. Moss SE, Klein R., Klein BE The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1999 ; 22: 951-959. (Pubitemid 29241051)
6. Ramsey SD, Newton K., Blough D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999 ; 22: 382-387. (Pubitemid 29106890)
7. Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 2001 ; 17: 246-249. (Pubitemid 32821657)
8. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J., Schaper NC Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005 ; 48: 1906-1910. (Pubitemid 41317847)
9. Valensi P., Girod I., Baron F., Moreau-Defarges G., Guillon P. Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes Metab. 2005 ; 31: 263-271. (Pubitemid 40961523)
10. Gordois A., Scuffham P., Shearer A., Oglesby A. The health care costs of diabetic peripheral neuropathy in the UK. The Diabetic Foot. 2003 ; 6: 62-73.
11. Gordois A., Scuffham P., Shearer A., Oglesby A., Tobian JA The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003 ; 26: 1790-1795. (Pubitemid 36929121)
12. Broughton G., Janis JE, Attinger CE The basic science of wound healing. Plast Reconstr Surg. 2006 ; 117: 12S - 34S. (Pubitemid 44317769)
13. Galkowska H., Wojewodzka U., Olszewski WL Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 2006 ; 14: 558-565. (Pubitemid 44470072)
14. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003 ; 83: 835-870. (Pubitemid 36828927)
15. Barrientos S., Stojadinovic O., Golinko MS, Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008 ; 16: 585-601.
16. Loots MA, Lamme EN, Zeegelaar J., Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol. 1998 ; 111: 850-857. (Pubitemid 28509329)
17. Piaggesi A., Viacava P., Rizzo L., et al. Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetes Care. 2003 ; 26: 3123-3128. (Pubitemid 37339508)
18. Galkowska H., Wojewodzka U., Olszewski WL Low recruitment of immune cells with increased expression of endothelial adhesion molecules in margins of the chronic diabetic foot ulcers. Wound Repair Regen. 2005 ; 13: 248-254. (Pubitemid 40848017)
19. Jude EB, Blakytny R., Bulmer J., Boulton AJ, Ferguson MW Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med. 2002 ; 19: 440-447. (Pubitemid 34639153)
20. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988 ; 334: 260-262. (Pubitemid 18173378)
21. Gillitzer R., Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001 ; 69: 513-521. (Pubitemid 32294835)
22. Dickinson PJ, Carrington AL, Frost GS, Boulton AJ Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev. 2002 ; 18: 260-272.
23. Chen WY, Rogers AA Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds. Wound Repair Regen. 2007 ; 15: 434-449. (Pubitemid 47087635)
24. Eming SA, Brachvogel B., Odorisio T., Koch M. Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem. 2007 ; 42: 115-170. (Pubitemid 350016248)
25. Brem H., Jacobs T., Vileikyte L., et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg Technol Int. 2003 ; 11: 85-92.
26. Martin A., Komada MR, Sane DC Abnormal angiogenesis in diabetes mellitus. Med Res Rev. 2003 ; 23: 117-145. (Pubitemid 36241095)
27. Teixeira AS, Andrade SP Glucose-induced inhibition of angiogenesis in the rat sponge granuloma is prevented by aminoguanidine. Life Sci. 1999 ; 64: 655-662. (Pubitemid 29083178)
28. Hickey MM, Simon MC Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol. 2006 ; 76: 217-257.
29. Fong GH Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis. 2008 ; 11: 121-140.
30. Catrina SB, Okamoto K., Pereira T., Brismar K., Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes. 2004 ; 53: 3226-3232. (Pubitemid 39564499)
31. Pipili-Synetos E., Sakkoula E., Haralabopoulos G., Andriopoulou P., Peristeris P., Maragoudakis ME Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol. 1994 ; 111: 894-902. (Pubitemid 24151681)
32. Jude EB, Boulton AJ, Ferguson MW, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia. 1999 ; 42: 748-757. (Pubitemid 29265594)
33. Jude EB, Tentolouris N., Appleton I., Anderson S., Boulton AJ Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers. Wound Repair Regen. 2001 ; 9: 353-359. (Pubitemid 34038763)
34. Vodovotz Y. Control of nitric oxide production by transforming growth factor-beta1: mechanistic insights and potential relevance to human disease. Nitric Oxide. 1997 ; 1: 3-17. (Pubitemid 28078123)
35. Grotendorst GR, Soma Y., Takehara K., Charette M. EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol. 1989 ; 139: 617-623. (Pubitemid 19167836)
36. Pierce GF, Tarpley JE, Yanagihara D., Mustoe TA, Fox GM, Thomason A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol. 1992 ; 140: 1375-1388.
37. Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995 ; 270: 27348-27357.
38. Castronuovo JJ Jr, Ghobrial I., Giusti AM, Rudolph S., Smiell JM Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gel. Am J Surg. 1998 ; 176: 61S - 67S. (Pubitemid 28460659)
39. Blakytny R., Jude EB, Martin Gibson J., Boulton AJ, Ferguson MW Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol. 2000 ; 190: 589-594. (Pubitemid 30164489)
40. Kawamoto K., Matsuda H. Nerve growth factor and wound healing. Prog Brain Res. 2004 ; 146: 369-384. (Pubitemid 37541394)
41. Galkowska H., Olszewski WL, Wojewodzka U., Rosinski G., Karnafel W. Neurogenic factors in the impaired healing of diabetic foot ulcers. J Surg Res. 2006 ; 134: 252-258. (Pubitemid 44092816)
42. Guvakova MA Insulin-like growth factors control cell migration in health and disease. Int J Biochem Cell Biol. 2007 ; 39: 890-909. (Pubitemid 46575318)
43. Reed MJ, Vernon RB, Abrass IB, Sage EH TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol. 1994 ; 158: 169-179. (Pubitemid 2004255)
44. Roberts AB Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen. 1995 ; 3: 408-418.
45. Telasky C., Tredget EE, Shen Q., et al. IFN-alpha2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. J Interferon Cytokine Res. 1998 ; 18: 571-577. (Pubitemid 28391584)
46. Kuroda K., Utani A., Hamasaki Y., Shinkai H. Up-regulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts. J Dermatol Sci. 2001 ; 26: 156-160. (Pubitemid 32510724)
47. Heldin CH, Eriksson U., Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys. 2002 ; 398: 284-290.
48. Hehenberger K., Kratz G., Hansson A., Brismar K. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci. 1998 ; 16: 144-151. (Pubitemid 128771612)
49. Loot MA, Kenter SB, Au FL, et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol. 2002 ; 81: 153-160. (Pubitemid 34308679)
50. Cavallini M. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients. Wound Repair Regen. 2007 ; 15: 35-38. (Pubitemid 46146660)
51. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest. 1990 ; 63: 825-831.
52. Trengove NJ, Stacey MC, MacAuley S., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999 ; 7: 442-452. (Pubitemid 30027566)
53. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004 ; 16: 558-564. (Pubitemid 39201241)
54. Gill SE, Parks WC Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol. 2008 ; 40: 1334-1347.
55. Rundhaug JE Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005 ; 9: 267-285.
56. Lambert E., Dasse E., Haye B. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004 ; 49: 187-198. (Pubitemid 38251351)
57. Rechardt O., Elomaa O., Vaalamo M., et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol. 2000 ; 115: 778-787.
58. Armstrong DG, Jude EB The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc. 2002 ; 92: 12-18.
59. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002 ; 45: 1011-1016. (Pubitemid 34762196)
60. Pirilä sign E., Korpi JT, Korkiam signki T., et al. Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies. Wound Repair Regen. 2007 ; 15: 47-57. (Pubitemid 46146662)
61. Edwards DR, Murphy G., Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987 ; 6: 1899-1904.
62. Yamamoto T., Eckes B., Mauch C., Hartmann K., Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol. 2000 ; 164: 6174-6179. (Pubitemid 30408794)
63. Moore KW, de Waal Malefyt R., Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001 ; 19: 683-765. (Pubitemid 32368050)
64. Philips N., Keller T., Gonzalez S. TGF beta-like regulation of matrix metalloproteinases by anti-transforming growth factor-beta, and anti-transforming growth factor-beta 1 antibodies in dermal fibroblasts: Implications for wound healing. Wound Repair Regen. 2004 ; 12: 53-59. (Pubitemid 38249136)
65. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., Tamaki K. Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol. 2006 ; 25: 202-212. (Pubitemid 43729072)
66. Harding KG, Morris HL, Patel GK Science, medicine and the future: healing chronic wounds. BMJ. 2002 ; 324: 160-163. (Pubitemid 34084511)
67. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003 ; 90: 133-146. (Pubitemid 36237887)
68. Rennekampff HO, Hansbrough JF, Kiessig V., Doré C., Sticherling M., Schréder JM Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res. 2000 ; 93: 41-54.
69. Yano S., Komine M., Fujimoto M., Okochi H., Tamaki K. Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun. 2003 ; 301: 841-847. (Pubitemid 36279190)
70. Botchkarev VA, Yaar M., Peters EM, et al. Neurotrophins in skin biology and pathology. J Invest Dermatol. 2006 ; 126: 1719-1727. (Pubitemid 44086504)
71. Roosterman D., Goerge T., Schneider SW, Bunnett W., Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev. 2006 ; 86: 1309-1379. (Pubitemid 44523706)
72. Bandyopadhyay B., Fan J., Guan S., et al. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol. 2006 ; 172: 1093-1105.
73. Stojadinovic O., Brem H., Vouthounis C., et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005 ; 167: 59-69. (Pubitemid 40884770)
74. Usui ML, Mansbridge JN, Carter WG, Fujita M., Olerud JE Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem. 2008 ; 56: 687-696.
75. Ryan MC, Lee K., Miyashita Y., Carter WG Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol. 1999 ; 145: 1309-1323. (Pubitemid 29293640)
76. Gibran NS, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res. 2002 ; 108: 122-128. (Pubitemid 35373824)
77. Lindsay RM, Lockett C., Sternberg J., Winter J. Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience. 1989 ; 33: 53-65. (Pubitemid 20032975)
78. Yasuda H., Terada M., Maeda K., et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol. 2003 ; 69: 229-285. (Pubitemid 36581874)
79. Antezana M., Sullivan S., Usui M., et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol. 2002 ; 119: 1400-1404. (Pubitemid 36005627)
80. Muangman P., Spenny ML, Tamura RN, Gibran NS Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells. Shock. 2003 ; 19: 508-512.
81. Steinhoff M., Stäsignnder S., Seeliger S., Ansel JC, Schmelz M., Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003 ; 139: 1479-1488. (Pubitemid 37433137)
82. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003 ; 17: 24-38. (Pubitemid 36410972)
83. Monboisse JC, Borel JP Oxidative damage to collagen. EXS. 1992 ; 62: 323-327.
84. Kennett EC, Davies MJ Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism. Free Radic Biol Med. 2007 ; 42: 1278-1289. (Pubitemid 46428518)
85. Culcasi M., Lafon-Cazal M., Pietri S., Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem. 1994 ; 269: 12589-12593. (Pubitemid 24202045)
86. Beckman JS, Beckman TW, Chen J., Marshall PA, Freeman BA Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 ; 87: 1620-1624. (Pubitemid 20080360)
87. Mudge BP, Harris C., Gilmont RR, Adamson BS, Rees RS Role of glutathione redox dysfunction in diabetic wounds. Wound Repair Regen. 2002 ; 10: 52-58. (Pubitemid 34496481)
88. Hinchliffe RJ, Valk GD, Apelqvist J., et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008 ; 24 (suppl 1). S119 - S144.
89. Eming SA, Krieg T., Davidson JM Gene therapy and wound healing. Clin Dermatol. 2007 ; 25: 79-92. (Pubitemid 46177464)
90. Vojtassak J., Danisovic L., Kubes M., et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett. 2006 ; 27 (suppl 2). 134-137. (Pubitemid 46534356)